The stable gastric pentadecapeptide BPC 157, an original cytoprotective antiulcer peptide that is used in ulcerative colitis and recently in a multiple sclerosis trial and that has an LD1 that has not been achieved [1,2,3,4,5,6,7,8,9,10,11], is known to have pleiotropic beneficial effects [1,2,3,4,5,6,7,8,9,10,11] and to interact with several molecular pathways [2, 27,28,29,30,31,32]
Cycle length 8 weeks Where it comes from Community research planning How to label it Anecdotal Cycle length 12 weeks Where it comes from Published trial duration and community planning How to label it Published and community context Cycle length 16 weeks Where it comes from Community research planning How to label it Anecdotal Cycle length 24 weeks Where it comes from Published trial duration How to label it Published research Read the full AOD-9604 cycle-length guide for a closer look at 8-, 12-, 16-, and 24-week timelines
What Medical Conditions Peptides May Help Treat
A real big portion supplement